News Archive of PR Leap - Biotech

ArticleAdded
SHEL LAB Introduces the Bactrox Chamber05-10-12
Abcam Launches Potent, Novel Dynamin Inhibitor Licensed from the University of Newcastle and Children's Medical Research Institute04-04-12
Abcam Biochemicals is launched; the new name for Ascent Scientific products01-11-12
AL-TAR Services, Inc. Adds Thermo-Scientific Product Line to its Online Lab Equipment Store11-14-11
Ascent Scientific Launch Novel Dynamin Inhibitor Dyngo-4a™ with Children's Medical Research Institute and University of Newcastle11-01-11
AL-TAR Services, Inc. Names Robert Nugent Director of Business Development10-14-11
Ascent Scientific licenses novel clathrin inhibitors from Freie Universität Berlin, University of Newcastle and Children's Medical Research Institute10-08-11
Expanded serotonin, nicotine and dopamine ranges, and exclusive dynamin inhibitors toolbox available in Ascent Scientific's new Low-Cost Ligand™ catalogue09-08-11
Thermablok's NASA Technology Aerogel Used to Insulate Solar Autoclave, Address Long-Standing Health Issue for Developing Countries05-11-11
NeuroHealing Announces Treatment of First Patient in NH001 Coma Clinical Study05-03-11
NeuroHealing Receives Notice of Allowance from the U.S. Patent and Trademark Office for a New Treatment for Premature Ejaculation10-13-10
Ascent Scientific Licenses Novel Light-Sensitive Caged Ligands from Columbia University09-25-10
Ascent Scientific Licenses Novel Dynamin Toolkits from Children's Medical Research Institute and University of Newcastle03-16-11
Insight Realm Inc. Announces Cancer Findings10-18-10
SOURCESOLUTION AND BIOPROCESSUK ANNOUNCE CO-MARKETING AGREEMENT08-27-09
Interim Results of Phase II Trial for the Treatment of Sialorrhea to be Presented at Movement Disorder Society International Congress June 11th06-09-09
Save the Cord Foundation Claims Cord Blood Stem Cells Overlooked Because of Public Banking Versus Private Donation Debate 03-19-09
Vivante GMP Solutions, Inc. Completes Process Optimization Contract for Oxford University Malaria Vaccine10-09-09
Venture Planning Group Publishes New Study on the In-Vitro Diagnostics Market 2009-201810-04-09
Vivante GMP Solutions, Inc. formed through purchase of GMP assets from Introgen Therapeutics; Formally launches business09-18-09
Ascent Scientific launches UCPH-101, a novel selective EAAT1 inhibitor09-16-09
Executive Impact Group Provides Startup Solutions to VC funded $40M Calithera Biosciences07-29-10
Vivante GMP Solutions Announces Expansion of Technical Staff07-08-10
Vivante GMP Solutions Announces Successful Completion of GMP Manufacture, Lot Release Campaign05-18-10
SourceSolution Announces the Implementation of the PlanIt Partner Portal for Vivante GMP Solutions04-27-10
Vivante GMP Solutions Announces Successful Completion of GMP Fill/Finish, Lot Release Campaign for Etubics Corporation04-07-10
Vivante GMP Solutions, Aseptic Technologies Team Up To Address Viral Fill Opportunities03-25-10
Vivante GMP Solutions Completes Successful QP Audit of GMP Facility and Quality Systems 03-11-10
SourceSolution Launches Client Portal Software, PlanIt, for CMOs/CROs and their Biotech and Pharma Clients02-25-10
Vivante GMP Solutions Enters into License Agreements with Crucell02-17-10
Ascent Scientific Licenses Novel Columbia University Technology for High-Resolution Optical Imaging of Synaptic Activity in the Brain 02-13-10
World First - Green Cell Technologies' Extraction Process reduces plant & micro-organisms to a stabilised molecular level 02-12-10
SourceSolution Announced Today the Launch of New Website Features Designed to Support Biotechnology and Pharmaceutical Strategic Sourcing Decisions11-12-09
New Vice President of Production Joins Vivante GMP Solutions' Team10-27-09